“redmile-group” Archives

in
Entry Author Date Location
Annexon Adds On $100M to Advance Antibodies to Treat Neurodegeneration 07/01/20 San Francisco
Invitae Makes a Precision Oncology Push With $886M Deal for ArcherDx 06/22/20 San Francisco
Shattuck Labs Nabs $118M for Cancer Drugs Like Keytruda, But Better 06/19/20 Raleigh Durham
Kymera Closes $102M Round to Bring Protein-Busting Drugs to the Clinic 03/12/20 Boston
Amunix Raises $73M to Bring Safer T Cell Engagers to Solid Tumors 03/04/20 San Francisco
Novartis Leads $100M Round for Fibrosis-Focused Pliant Therapeutics 03/03/20 San Francisco
With Ex-Medivation Exec Hung at Helm, Nuvation Nabs $275M for Cancer 10/28/19 New York
With $120M, AlloVir Faces Big Test of Cell Therapy to Fight Infection 05/22/19 Texas
ElevateBio Gets $150M to Grow a Crop of Gene & Cell Therapy Startups 05/13/19 Boston
Neurogene Emerges with $68M to Advance Gene Therapies to the Clinic 02/12/19 New York
With $90M Round, Stoke Eyes a “Spinraza For Epilepsy” And a 2019 IPO 10/23/18 Boston
OncoResponse Nabs $40M for Cancer Drugs Based On Survivors’ Antibodies 09/11/18 Texas
Backed by $37M, Virta Tries Tech Approach to “Reverse” Diabetes 03/08/17 San Francisco
Austin Biotech Xeris Names Edick CEO, Raises $41M in Series C Round 01/10/17 Texas
Augmedix Garners $23,000,000 New Funding Round 12/09/16 San Francisco
Augmedix, Vida Health Land New VC Money For Digital Health Services 12/08/16 San Francisco
Genalyte Garners $36,000,000 New Round 11/22/16 San Diego
Science 37 Obtains $31,000,000 Series B Financing Round 10/19/16 San Diego
True North Therapeutics Lands $45,000,000 Series D Funding 10/19/16 San Francisco
Syros Files For IPO to Push “Gene Control” Drugs Through First Trials 06/06/16 Boston
Augmedix Plans To Expand Google Glass-Based System For Healthcare 04/28/16 San Francisco
Augmedix Receives $17,000,000 New Financing 04/25/16 San Francisco
Yumanity Secures $45,000,000 Series A Financing 02/11/16 Boston
One Year Post-Launch, Yumanity Lands $45M For Yeasty Discovery 02/10/16 Boston
Eyeing First Trials, Syros Brings in $40M and More Crossovers 01/13/16 Boston
Syros Pharmaceuticals Garners $40,000,000 New Financing 01/13/16 Boston
Xeris Pharmaceuticals Secures $41,000,000 Series C Funding Round 01/12/16 Texas
Cancer Vaccines Back in Vogue as VCs Put $102M Into Gritstone Oncology 10/20/15 San Francisco
Audentes Therapeutics Garners $65,000,000 Series C Funding 10/14/15 San Francisco
Genalyte Secures $44,000,000 Series C Financing 08/19/15 San Diego
Page 1 of 2 next page »